{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:06:41Z","timestamp":1788091601869,"version":"build-2803163510"},"reference-count":34,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2023,1,30]]},"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Atrial functional mitral regurgitation (AFMR) is characterised by left atrial and consequent mitral annular dilatation causing mitral regurgitation. AFMR is likely to become more common with population ageing, alongside increases in atrial fibrillation and heart failure with preserved ejection fraction; conditions causing atrial dilatation. Here, we aim to define the prevalence and characterise the patient and survival characteristics of AFMR in the National Echocardiographic Database of Australia (NEDA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>14 004 adults with moderate or severe FMR were identified from NEDA. AFMR or ventricular FMR (VFMR) was classified by LA size, LV size and LVEF. AFMR was found in 40% (n=5562) and VFMR in 60% (n=8442). Compared with VFMR, the AFMR subgroup were significantly older (mean age 78\u00b111 years), with a higher proportion of females and of AF. Participants were followed up for a median of 65 months (IQR 36\u2013116 months). After adjustment for age, sex, AF, and pulmonary hypertension, the prognosis for VFMR was significantly worse than for AFMR (HR 1.57, 95% CI 1.47 to 1.68 for all-cause and 1.73, 95% CI 1.60 to 1.88, p&lt;0.001 for both). After further adjustment for LVEF, mortality rates were similar in VFMR and AFMR patients (HR 0.93, p=NS), though advancing age and pulmonary hypertension remained independently associated with prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AFMR is a common cause of significant functional MR that predominantly affects elderly female patients with AF. Advancing age and pulmonary hypertension independently associated with survival in FMR. Prognosis was better in AFMR compared with VFMR; however, this difference was accounted for by LV systolic impairment and not by MR severity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2022-002180","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T11:11:20Z","timestamp":1676459480000},"page":"e002180","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":44,"title":["Atrial functional mitral regurgitation: prevalence, characteristics and outcomes from the National Echo Database of Australia"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0039-3911","authenticated-orcid":false,"given":"Avalon","family":"Moonen","sequence":"first","affiliation":[{"name":"School of Medicine, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K C","family":"Ng","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Playford","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Notre Dame Australia, Fremantle, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6800-7119","authenticated-orcid":false,"given":"Geoff","family":"Strange","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Notre Dame Australia, Fremantle, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M","family":"Scalia","sequence":"additional","affiliation":[{"name":"The University of Queensland, Saint Lucia, Queensland, Australia"},{"name":"Department of Cardiology, The Prince Charles Hospital, Chermside, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Celermajer","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"2025081709494935000_10.1.e002180.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw229"},{"key":"2025081709494935000_10.1.e002180.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69208-8"},{"key":"2025081709494935000_10.1.e002180.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.03.459"},{"key":"2025081709494935000_10.1.e002180.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60692-9"},{"key":"2025081709494935000_10.1.e002180.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.02.061"},{"key":"2025081709494935000_10.1.e002180.6","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1056\/NEJMcp1903331","article-title":"Secondary mitral regurgitation","volume":"383","author":"O\u2019Gara","year":"2020","journal-title":"N Engl J Med"},{"key":"2025081709494935000_10.1.e002180.7","doi-asserted-by":"crossref","DOI":"10.1007\/s11936-020-00830-0","article-title":"Atrial functional mitral and tricuspid regurgitation","volume":"22","author":"Deferm","year":"2020","journal-title":"Curr Treat Options Cardio Med"},{"key":"2025081709494935000_10.1.e002180.8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006239","article-title":"Atrial functional mitral regurgitation: from mitral annulus dilatation to insufficient leaflet remodeling","volume":"10","author":"Delgado","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025081709494935000_10.1.e002180.9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jcmg.2021.02.008","article-title":"Severe atrial functional mitral regurgitation: clinical and echocardiographic characteristics, management and outcomes","volume":"14","author":"Mesi","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025081709494935000_10.1.e002180.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz314"},{"key":"2025081709494935000_10.1.e002180.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2018.07.001"},{"key":"2025081709494935000_10.1.e002180.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.08.004"},{"key":"2025081709494935000_10.1.e002180.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.03.482"},{"key":"2025081709494935000_10.1.e002180.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"2025081709494935000_10.1.e002180.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000503"},{"key":"2025081709494935000_10.1.e002180.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.536"},{"key":"2025081709494935000_10.1.e002180.17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ehf2.12491","article-title":"Echocardiographic assessment of functional mitral regurgitation: opening Pandora\u2019s box?","volume":"6","author":"Hagendorff","year":"2019","journal-title":"ESC Heart Fail"},{"key":"2025081709494935000_10.1.e002180.18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ehjci\/jeaa253","article-title":"Diastolic dysfunction and mortality in 436 360 men and women: the National echo database Australia (NEDA)","volume":"22","author":"Playford","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025081709494935000_10.1.e002180.19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijcard.2020.06.042","article-title":"Outcomes and predictors of cardiac events in medically treated patients with atrial functional mitral regurgitation","volume":"316","author":"Kim","year":"2020","journal-title":"Int J Cardiol"},{"key":"2025081709494935000_10.1.e002180.20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jjcc.2020.12.002","article-title":"A new disease entity: atrial functional mitral regurgitation","volume":"77","author":"Abe","year":"2021","journal-title":"J Cardiol"},{"key":"2025081709494935000_10.1.e002180.21","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.813"},{"key":"2025081709494935000_10.1.e002180.22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ejhf.1699","article-title":"Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction","volume":"22","author":"Tamargo","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2025081709494935000_10.1.e002180.23","doi-asserted-by":"crossref","unstructured":"Wagner CM , Brescia AA , Watt TMF , et al . Surgical strategy and outcomes for atrial functional mitral regurgitation: all functional mitral regurgitation is not the same! J Thorac Cardiovasc Surg 2022:00373-7. doi:10.1016\/j.jtcvs.2022.02.056","DOI":"10.1016\/j.jtcvs.2022.02.056"},{"key":"2025081709494935000_10.1.e002180.24","first-page":"1124","article-title":"Impact of left ventricular function on clinical outcomes of functional mitral regurgitation patients undergoing transcatheter mitral valve repair","volume":"88","author":"Azzalini","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025081709494935000_10.1.e002180.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.11.006"},{"key":"2025081709494935000_10.1.e002180.26","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001574","article-title":"Prognostic comparison of atrial and ventricular functional mitral regurgitation","volume":"8","author":"Okamoto","year":"2021","journal-title":"Open Heart"},{"key":"2025081709494935000_10.1.e002180.27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jcmg.2021.03.003","article-title":"Atrial secondary mitral regurgitation: often overlooked, but never forgotten","volume":"14","author":"Lancellotti","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025081709494935000_10.1.e002180.28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jjcc.2018.04.002","article-title":"Prevalence, clinical characteristics, and outcome of atrial functional mitral regurgitation in hospitalized heart failure patients with atrial fibrillation","volume":"72","author":"Saito","year":"2018","journal-title":"J Cardiol"},{"key":"2025081709494935000_10.1.e002180.29","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1253\/circj.CJ-20-0135","article-title":"JCS\/JSCS\/JATS\/JSVS 2020 guidelines on the management of valvular heart disease","volume":"84","author":"Izumi","year":"2020","journal-title":"Circ J"},{"key":"2025081709494935000_10.1.e002180.30","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113432","article-title":"Mitral valve repair of atrial functional mitral regurgitation in heart failure with preserved ejection fraction","volume":"9","author":"Balogh","year":"2020","journal-title":"J Clin Med"},{"key":"2025081709494935000_10.1.e002180.31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010300","article-title":"Implications of atrial fibrillation on the mechanisms of mitral regurgitation and response to mitraclip in the COAPT trial","volume":"14","author":"Gertz","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"2025081709494935000_10.1.e002180.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.06.032"},{"key":"2025081709494935000_10.1.e002180.33","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jcin.2022.07.004","article-title":"Outcomes after transcatheter edge-to-edge mitral valve repair according to mitral regurgitation etiology and cardiac remodeling","volume":"15","author":"Yoon","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2025081709494935000_10.1.e002180.34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijcard.2021.11.027","article-title":"Transcatheter edge-to-edge mitral valve repair in atrial functional mitral regurgitation: insights from the multi-center MITRA-TUNE registry","volume":"349","author":"Popolo Rubbio","year":"2022","journal-title":"Int J Cardiol"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2022-002180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:50:02Z","timestamp":1755449402000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2022-002180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,2,15]]},"published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1136\/openhrt-2022-002180"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2022-002180","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}